Koh Tricia Jia Wen, Tan Hannah Jia Hwee, Ravi Priscilla Roshini Joseph, Sng Jonathan W Z, Yeo Tiong-Cheng, Tan Benjamin Y Q, Chai Ping, Yeo Leonard L L, Chan Mark Y, Kong William K F, Wong Raymond C C, Teo Yao Hao, Ho Jamie Sin Ying, Teo Yao Neng, Sia Ching-Hui
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Department of Diagnostic Imaging, National University Hospital, Singapore.
Can J Cardiol. 2023 Dec;39(12):1941-1950. doi: 10.1016/j.cjca.2023.07.024. Epub 2023 Jul 26.
Recent studies have shown that breast arterial calcification (BAC) detected on screening mammography is linked to cardiovascular diseases via medial calcification. However, its effect on cardiovascular outcomes remains unclear. Therefore, we conducted a meta-analysis to determine the effect of BAC on cardiovascular outcomes in patients.
Three electronic databases (Pubmed, Embase, and Scopus) were searched on May 1, 2022, for studies examining the relationship between BAC and cardiovascular outcomes including cardiac death, acute myocardial infarction, ischemic heart disease, stroke, peripheral artery disease, and heart failure. A random-effects meta-analysis model was used to summarise the studies.
A total of 5 longitudinal studies were included with a combined cohort of 87,865 patients. Significantly, the pooled risk ratio (RR) of the association between BAC and cardiac death was 2.06 (P < 0.00001). BAC was associated with a significantly increased risk of developing other cardiovascular diseases, such as ischemic/hemorrhagic stroke (RR 1.51; P = 0.003), ischemic stroke (RR 1.82; P < 0.00001), peripheral vascular disease (RR 1.24; P = 0.003), and heart failure (RR 1.84; P < 0.00001). There was no significant relationship for developing myocardial infarction or for total cardiovascular diseases.
Our findings suggest that BAC was associated with an increased risk of cardiovascular mortality, and certain cardiovascular outcomes. There is thus a potential to use BAC as a sex-specific cardiovascular risk assessment tool. Furthermore, there is a need for more widespread reporting of BAC to better understand the pathophysiologic mechanisms behind its correlation with cardiovascular disease and to apply it in clinical practice.
近期研究表明,筛查乳腺钼靶检查中发现的乳腺动脉钙化(BAC)通过中层钙化与心血管疾病相关联。然而,其对心血管结局的影响仍不明确。因此,我们进行了一项荟萃分析,以确定BAC对患者心血管结局的影响。
于2022年5月1日在三个电子数据库(PubMed、Embase和Scopus)中检索研究BAC与心血管结局(包括心源性死亡、急性心肌梗死、缺血性心脏病、中风、外周动脉疾病和心力衰竭)之间关系的研究。采用随机效应荟萃分析模型对研究进行汇总。
共纳入5项纵向研究,合并队列有87,865例患者。值得注意的是,BAC与心源性死亡之间关联的合并风险比(RR)为2.06(P < 0.00001)。BAC与发生其他心血管疾病的风险显著增加相关,如缺血性/出血性中风(RR 1.51;P = 0.003)、缺血性中风(RR 1.82;P < 0.00001)、外周血管疾病(RR 1.24;P = 0.003)和心力衰竭(RR 1.84;P < 0.00001)。发生心肌梗死或总的心血管疾病无显著关系。
我们的研究结果表明,BAC与心血管死亡率增加及某些心血管结局相关。因此,有可能将BAC用作特定性别的心血管风险评估工具。此外,需要更广泛地报告BAC,以更好地了解其与心血管疾病相关性背后的病理生理机制,并将其应用于临床实践。